FDA, researchers consider first transgenic fish

Researchers consider value-of-information theory for selecting trials.

O ncology faces a dilemma with newer cancer drugs that are both too expensive and not effective enough, according to critics. Now some researchers and economists say that there’s a way to address that problem while drugs are still in the pipeline. Called value-of-information (VOI) theory, it can be used when deciding which clinical trials to fund, according to Larry Baker, D.O., a professor of ...

Mapping and Analyzing the Co-Authorship Network of Transgenic Researchers with a Network Analysis Approach

Background and Aim: Transgenic species are the ones whose genomes are genetically modified. The transgenic field is one of the areas that has a high importance and position in the world. Therefore, the aim of the present research is to draw and analyze the co-authorship network of researchers in transgenic subject area. Materials and Methods: The type of this research is descriptive and was ca...

Transgenic fish and aquaculture

Transgenic fish species can be routinely produced by transferring foreign DNA into developing embryos via microinjection or electroporation. This technology offers an excellent opportunity for modifying or improving the genetic traits of commercially important Fishes, mollusks, and crustaceans for aquaculture. Studies have shown that administration of recombinant fish or mammalian growth hormon...

Researchers’ First Duty Is to the Participants

Transgenic fish. The future 1 of fish with novel genes

Making transgenic lines of vertebrates represents a rather new technology. While transgenic fish have been introduced in the laboratory since the n id eighties, it has also becolne a reality in aquaculture since the early nineties. There are many reasons why people want to create genetically modified organisms (GMO) and there are many strategies to nlake "fish with novel genes". As such it ...